Phase 1 Study of Ulixertinib (BVD 523) in Patients with Advanced Solid Malignancies
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
RNAseq from tumor samples of patients treated on clinical trial Pretreatment biopsies were obtained from responders and non-responders
应用场景：
创建时间：
2023-02-16
相关数据集
DataSheet1_Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma.PDF
Mantle cell lymphoma (MCL) is an incurable B cell non-Hodgkin lymphoma, characterized by frequent relapses. In the last decade, the pro-survival pathways related to BCR signaling and Bcl-2 have been c
NIAID Data Ecosystem20
Highly selective HSP90 inhibitor, pimitespib, demonstrates its potent growth suppressive activity to adult T-cell leukemia in preclinical models (ED).. Highly selective HSP90 inhibitor, pimitespib, demonstrates its potent growth suppressive activity to adult T-cell leukemia in preclinical models (ED).
Adult T-cell leukaemia-lymphoma (ATL) is a highly chemoresistant malignancy of peripheral T lymphocytes caused by human T-lymphotropic virus type I (HTLV-1). ATL cells constitutively activate anti-apo
NIAID Data Ecosystem10
Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate Dehydrogenase. Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate Dehydrogenase
Agents targeting metabolic pathways form the backbone of standard oncology treatments, though a better understanding of differential metabolic dependencies could instruct more rationale-based therapeu
NIAID Data Ecosystem10
Furin Targeted Drug Delivery for Treatment of Rhabdomyosarcoma in a Mouse Model
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. Improvement of treatment efficacy and decreased side effects through tumor-targeted drug delivery would be desirable. By pann
NIAID Data Ecosystem10
Dual targeted extracellular vesicles regulating oncogenic genes in pancreatic cancer [Human Array]. Dual targeted extracellular vesicles regulating oncogenic genes in pancreatic cancer [Human Array]
Pancreatic ductal adenocarcinoma (PDAC) tumors carry multiple gene mutations and respond poorly to treatments. There is currently an unmet need for drug carriers that can deliver multiple gene cargoes
NIAID Data Ecosystem10
